Publications by authors named "Joseph Hendrick"

Claim this Profile
I
Inhibition of calcium-calmodulin-dependent phosphodiesterase (PDE1) suppresses inflammatory responses.
Jennifer J O'Brien, James P O'Callaghan, Diane B Miller, Suman Chalgeri, Lawrence P Wennogle, Joseph P Hendrick

Mol Cell Neurosci· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute Enhancement of Cardiac Function by Phosphodiesterase Type 1 Inhibition.
Toru Hashimoto, Grace E Kim, Richard S Tunin, Tolulope Adesiyun, Steven Hsu, Joseph P Hendrick

Circulation· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phosphodiesterase 1: A Unique Drug Target for Degenerative Diseases and Cognitive Dysfunction.
Lawrence P Wennogle, Helen Hoxie, Youyi Peng, Joseph P Hendrick

Adv Neurobiol· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical profile of ITI-214, an inhibitor of phosphodiesterase 1, for enhancement of memory performance in rats.
Gretchen L Snyder, Jos Prickaerts, Marie-Louise Wadenberg, Lei Zhang, Hailin Zheng, Joseph P Hendrick

Psychopharmacology (Berl)· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of Potent and Selective Inhibitors of Phosphodiesterase 1 for the Treatment of Cognitive Impairment Associated with Neurodegenerative and Neuropsychiatric Diseases.
Peng Li, Hailin Zheng, Jun Zhao, Lei Zhang, Wei Yao, Joseph P Hendrick

J Med Chem· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional profile of a novel modulator of serotonin, dopamine, and glutamate neurotransmission.
Gretchen L Snyder, Kimberly E Vanover, Hongwen Zhu, Diane B Miller, James P O'Callaghan, Joseph P Hendrick

Psychopharmacology (Berl)· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of a tetracyclic quinoxaline derivative as a potent and orally active multifunctional drug candidate for the treatment of neuropsychiatric and neurological disorders.
Peng Li, Qiang Zhang, Albert J Robichaud, Taekyu Lee, John Tomesch, Joseph P Hendrick

J Med Chem· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Muscarinic receptors acting at pre- and post-synaptic sites differentially regulate dopamine/DARPP-32 signaling in striatonigral and striatopallidal neurons.
Mahomi Kuroiwa, Miho Hamada, Eriko Hieda, Takahide Shuto, Naoki Sotogaku, Joseph P Hendrick

Neuropharmacology· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gamma-secretase activating protein is a therapeutic target for Alzheimer's disease.
Gen He, Wenjie Luo, Peng Li, Christine Remmers, William J Netzer, Joseph Hendrick

Nature· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nerve agent exposure elicits site-specific changes in protein phosphorylation in mouse brain.
Hongwen Zhu, Jennifer J O'Brien, James P O'Callaghan, Diane B Miller, Qiang Zhang, Joseph P Hendrick

Brain Res· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
General anesthetics selectively modulate glutamatergic and dopaminergic signaling via site-specific phosphorylation in vivo.
Gretchen L Snyder, Stacey Galdi, Joseph P Hendrick, Hugh C Hemmings

Neuropharmacology· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of (S)-2-((S)-2-(3,5-difluorophenyl)-2-hydroxyacetamido)-N-((S,Z)-3-methyl-4-oxo-4,5-dihydro-3H-benzo[d][1,2]diazepin-5-yl)propanamide (BMS-433796): a gamma-secretase inhibitor with Abeta lowering activity in a transgenic mouse model of Alzheimer's disease.
C V C Prasad, Ming Zheng, Shikha Vig, Carl Bergstrom, David W Smith, Joseph P Hendrick

Bioorg Med Chem Lett· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of neuronal phosphoproteins as effectors of caffeine and mediators of striatal adenosine A2A receptor signaling.
Bogachan Sahin, Stacey Galdi, Joseph Hendrick, Robert W Greene, Gretchen L Snyder

Brain Res· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regulation of phosphorylation of the GluR1 AMPA receptor by dopamine D2 receptors.
Kerstin Håkansson, Stacey Galdi, Joseph Hendrick, Gretchen Snyder, Paul Greengard

J Neurochem· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nicotine regulates DARPP-32 (dopamine- and cAMP-regulated phosphoprotein of 32 kDa) phosphorylation at multiple sites in neostriatal neurons.
Miho Hamada, Joseph P Hendrick, Gregory R Ryan, Mahomi Kuroiwa, Hideho Higashi

J Pharmacol Exp Ther· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An inhibitor binding pocket distinct from the catalytic active site on human beta-APP cleaving enzyme.
Michael G Kornacker, Zhihong Lai, Mark Witmer, Jianghong Ma, Joseph Hendrick

Biochemistry· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis